Cancer Immunotherapy Developers Raise Nearly $150M in Financing – Genetic Engineering & Biotechnology News
|
Cancer Immunotherapy Developers Raise Nearly $150M in Financing
Genetic Engineering & Biotechnology News A pair of cancer immunotherapy developers have raised a combined nearly $150 million in Series B financings toward development of new platform technologies, treatments, and facilities. Gritstone Oncology, which aims initially to develop tumor-specific … |
